The United States federal government is aggressively pursuing criminal and civil whistleblower cases against pharmaceutical companies for promoting off-label uses of prescription drugs. Between 2003 and 2008, U.S. federal prosecutors and state attorneys general brought more than a dozen cases against drug makers for off-label marketing and won more than $6 billion in criminal and civil settlements
As you know, off-label use is the practice of prescribing pharmaceuticals for a purpose outside the scope of a drug’s approved label, most often concerning the drug’s indication.
It is legal in the United States and in many other countries to use drugs off-label, including controlled substances such as opiates, even though it is a common misconception that it is unlawful to do so.
However, it is unlawful to market, advertise or otherwise promote the off-label use of drugs, including controlled substances.
Read more: http://drugwhistleblower.com/ (this is our companion website to this site).